Chloroquine Diphosphate: Adverse Effects and Degradation Pathways
Chloroquine diphosphate has adverse effects and is susceptible to degradation. Proper storage and avoidance of interactions are crucial.
Feb 4，2024 API
How is Tolprocarb synthesised?
The synthesis of Tolprocarb was initiated by the carbamate coupling of trifluoroethyl chloroformate and valine under basic biphasic reaction conditions.
Feb 4，2024 Antimicrobial agent
Mandestrobin: Synthesis and Introduction
Mandestrobin is synthesised using 2,5-dimethylphenol as a raw material by chemical reaction.
Feb 4，2024 Antimicrobial agent
How is Oxathiapiprolin synthesised?
Oxathiapiprolin is synthesised using 4- cyanopiperidine as a raw material by chemical reaction.
Feb 4，2024 Antimicrobial agent
How to synthesis Relugolix?
Relugolix was recently approved for marketing in Japan as a treatment for symptoms associated with uterine fibroids.
Feb 2，2024 API
The role of NH4+ flame test
The NH4+ flame test, also known as the Ammonium flame test, is performed in a laboratory setting to identify the presence of ammonium ions (NH4+) in a given substance or solution.
Feb 2，2024 Inorganic salts
What is Iron flame test
The positive result of a flame test for iron (Fe) produces a golden color. This is due to the excitation of electrons in the sample by the flame's heat. As these electrons lose their energy, they emit
Feb 2，2024 Inorganic chemistry
The application of 2,5-Furandicarboxylic acid
2,5-Furandicarboxylic acid (FDCA), dehydromucic acid, is a furan derivative. FDCA is one of the top-12 value-added chemicals derived from biomass that may serve as a 'green' substitute for terephthali
Feb 2，2024 Organic reagents
Dabigatran Etexilate: A Potent Thrombin Inhibitor for Stroke Prevention in Non-Valvular Atrial Fibrillation
Dabigatran Etexilate, a prodrug converted to dabigatran, selectively inhibits clot formation. RE-LY trial showed noninferiority/superiority to warfarin in preventing stroke/embolism.
Feb 2，2024 API
Sunitinib in the Treatment of Thyroid Cancer
Sunitinib is a multi-targeted tyrosine kinase inhibitor used for various cancers, including thyroid cancer with specific gene rearrangements, demonstrating anti-tumor activity in clinical trials.
Feb 2，2024 API